1st Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$1,070,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; S. 2327 - Seniors Prescription Drug Relief Act; H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R.5260 - Reduced Costs and Continued Cures Act; H.R.5376 - Build Back Better Act - Part D Redesign, inflation penalty provisions; H.R. 2471- Consolidated Appropriations Act, 2022; Ensure patient access to behavioral health services and treatments through telehealth

LobbyistCovered position, as disclosed
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2471 (117th), H.R. 5260 (117th), H.R. 19 (117th), H.R. 3 (117th), H.R. 5376 (117th), S. 2327 (117th)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; H.R. 2471- Consolidated Appropriations Act, 2022; Expand funding and flexibility to address all substance use disorders; Prescription Drug User Fee Agreement reauthorization

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2471 (117th)

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; H.R.955 - Medicaid Reentry Act of 2021; H.R. 2471- Consolidated Appropriations Act, 2022

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: Justice, Dept of (DOJ); SENATE; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Executive Office of the President (EOP)

Bills named: H.R. 2471 (117th), H.R. 955 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.